Sabby Management, LLC V Tv Therapeutics Inc. Transaction History

Sabby Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$1.29 - $1.83 $287,891 - $408,404	-223,172 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$1.67 - $3.12 $372,697 - $696,296	223,172 New	223,172 $382,000
Q1 2018 May 15, 2018	SELL	$3.91 - $7.83 $173,995 - $348,435	-44,500 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$3.9 - $7.77 $63,948 - $127,404	-16,397 Reduced 26.93%	44,500 $267,000
Q3 2017 Nov 14, 2017	BUY	$3.83 - $6.07 $233,235 - $369,644	60,897	60,897 $364,000

243K

Ticker VTVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,483,600
Market Cap $1.14B
Description
vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetran...

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sabby Management, LLC with notifications on news.